PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
21280190-1	2011	Tacrolimus, a cornerstone immunosuppressant, is available as a twice-daily formulation (tacrolimus bid).	Tacrolimus	0-10	BH3 interacting domain death agonist	Homo sapiens	99-102	
21280190-1	2011	Tacrolimus, a cornerstone immunosuppressant, is available as a twice-daily formulation (tacrolimus bid).	Tacrolimus	88-98	BH3 interacting domain death agonist	Homo sapiens	99-102	
21280190-6	2011	Tacrolimus area under the curve (AUC) from 0 to 24 hours (AUC(0-24) ) at equivalent doses was approximately 50% lower for tacrolimus qd than for bid on day 1 (146 versus 264 ng   h/mL, respectively), but by day 14 was comparable between treatments (324 and 287 ng   h/mL, respectively) with higher tacrolimus qd doses.	Tacrolimus	0-10	BH3 interacting domain death agonist	Homo sapiens	145-148	
21280190-7	2011	There was a strong correlation between AUC(0-24) and concentration at 24 hours for tacrolimus qd and bid (r = 0.92 and r = 0.76, respectively).	Tacrolimus	83-93	BH3 interacting domain death agonist	Homo sapiens	101-104